Chapter 1. Introduction to Lung Diseases
Chapter 2. Targeting molecular and cellular mechanisms in asthma.-Chapter 3. Various cellular and molecular axis involved in the pathogenesis of asthma
Chapter 4. Targeting molecular and cellular mechanisms in steroid resistant asthma
Chapter 5. Targeting molecular and cellular mechanisms in chronic obstructive pulmonary disease
Chapter 6. Probing the cellular and molecular mechanisms underlying in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD)
Chapter 7. Chronic obstructive pulmonary disease: Molecular basis of pathogenesis and targeted therapeutic approaches
Chapter 8. Exploring the dormancy-activation switch in the tumour microenvironment for metastatic lung cancer: The possible role of microRNA
Chapter 9. Therapeutic strategies targeting signalling pathways in lung cancer
Chapter 10. Modulation of signalling pathways by immunotherapeutics in lung cancer
Chapter 11. Underpinning the Cellular and Molecular Mechanisms with Nanotheronstics for Lung Cancer
Chapter 12. Targeting molecular and cellular mechanisms in Idiopathic Pulmonary Fibrosis.-Chapter 13. A refined approach to target the molecular and cellular mechanisms in pulmonary fibrosis.-Chapter 14. Targeting molecular and cellular mechanisms in tuberculosis
Chapter 15. Cellular and Molecular Mechanisms of Repurposed antidiabetic drug as adjunctive treatment for tuberculosis
Chapter 16. Targeting host and bacterial signaling pathways in tuberculosis: An effective strategy for the development of novel anti-tubercular therapies
Chapter 17. Targeting molecular and cellular mechanisms in pulmonary hypertension
Chapter 18. Targeting molecular and cellular mechanisms in pulmonary arterial hypertension
Chapter 19. Potential cellular targets associated with the signaling and therapeutics of the pulmonary hypertension
Chapter 20. Targeting molecular and cellular mechanisms in influenza A virus infections
Chapter 21. Understanding the Biology of Non-typeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease through the Lens of Genomics
Chapter 22. Targeting molecular and cellular mechanisms in rhinovirus infection
Chapter 23. Targeting molecular and cellular mechanisms in respiratory syncytial virus (RSV) infection
Chapter 24. Targeting molecular and cellular mechanisms SARS-CoV2 novel corona (COVID-19) virus infection
Chapter 25. Underpinning the rudimentary mechanisms involved in the pathogenesis of SARS-CoV2 (COVID-19) in human lung cells
Chapter 26. Targeting molecular and cellular mechanisms in SARS-CoV2 novel corona (COVID-19) virus infection
Chapter 27. Special features of human lung ACE2 sensitivity to SARS CoV-2 spike glycoprotein
Chapter 28. Implications of Phosphoinositide 3-kinase (PI3K) Signalling in cellular and molecular mechanisms of respiratory diseases
Chapter 29. The role of the cholinergic system in lung diseases
Chapter 30. The Nrf2-Keap1 signaling pathway in lung cancer
Chapter 31. Role of Toll like receptor (LTR) in molecular and cellular mechanism of respiratory diseases
Chapter 32. Biomarkers of Oxidative Stress
Chapter 33. Targeting chronic lung diseases using advanced drug delivery systems
Chapter 34. Plant based chemical moieties targeting cellular signalling pathways in chronic lung diseases
Chapter 35. Role of phytoconstituents in targeting cytokines for managing pathophysiology of lung diseases
Chapter 36. Targeting Cellular Signaling Pathways in Lung Cancer and Role of Phytochemicals as Novel Therapeutic Approach
Chapter 37. Natural compounds targeting major signalling pathways in lung cancer
Chapter 38. Drug delivery in respiratory diseases: Current opportunities, Molecular and cellular mechanism, and Future challenges
Chapter 39. Future prospects and challenges in targeting cellular and molecular mechanisms in respiratory diseases.